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RESOURCES FOR MOMS: OPIATE USE
IN PREGNANCY

Amy Schumer
Family Medicine Clerkship
Springfield, VT
January 2016

PROBLEM IDENTIFICATION
Substance use in pregnancy is not uncommon and the use of substances increases the
risk of complications during pregnancy and of birth defects.
Vermont PRAMS data from 2012 indicated that 14% of women drank alcohol and
16% of women smoked during the last trimester of pregnancy. Despite these rates,
only 66.5% of mothers reported that their healthcare provider had discussed illicit
substance use and its side effects during their pregnancy.
During pregnancy, women can be highly motivated to change behaviors. One study
found that 57% of pregnant women using illicit drugs abstained during pregnancy.

OPIATE ADDICTION IN PREGNANCY
According to the 2013 National Survey on Drug use, 5.4% of pregnant women
reported illicit drug use in the past 30 days.
0.1% of pregnant women estimated to have used heroin

1.0% of pregnant women reported nonmedical use of opioid-containing medication
Infants exposed to opioids in utero are diagnosed as having neonatal abstinence
syndrome (NAS) at birth.

OPIATE ADDICTION IN VERMONT
Rate of emergency department visits
related to opioids has sharply
increased over the past 5 years. The
number of people in treatment
receiving either buprenorphine or
methadone has also increased.

Rates of infants exposed to opioids is
also on the rise.
Neonates Exposed to Opioids in Vermont, Vermont
Hospital Discharge Data Set, Vermont Department of
Health, June 2015

IMPACT ON THE FETUS
Nationally, neonatal abstinence syndrome
(NAS) cases have gone from 7 to 27 cases
per 1000 NICU admissions between 2003 and
2014.
In Vermont, infant hospital stay length is
shortening but remains longer than in nonopiate exposed infants.

Neonates Exposed to Opioids in Vermont, Vermont Hospital Discharge
Data Set, Vermont Department of Health, June 2015

Direct birth defects due to opiates are difficult to tease apart from coexisting medical,
nutritional, psychological and socioeconomic issues. Multiple complications, however, have
been associated with opiate use in pregnancy including:
Placental abruption, fetal death, intra-amniotic infection, fetal growth restriction, preeclampsia,
premature labor, premature rupture of membranes, and septic thrombophlebitis

COMMUNITY PERSPECTIVE
Julie Merrill, Learning Together Coordinator at the Springfield Area Parent Child
Center
 Discussed programs offered to moms requiring additional supports in the areas
of work skills, life skills, and parenting skills as well as their childcare center,
case management and Children’s Integrated Services (a comprehensive
program through DCF that babies born with NAS get automatically referred
to)
Lyndsy McIntyre, Nurse Manager of the ChildBirth Center at Springfield Hospital
 Discussed resources available to opiate using pregnant women in Springfield,
VT and the procedures in place for identifying opiate using women during
prenatal care and during hospital stay
 Feels more information is needed for pregnant women using opiates

COMMUNITY PERSPECTIVE, CONT.
James Walsh, PMH-NP at Springfield Health Center
 Discussed buprenorphine substitution therapy in pregnancy available through
the Windham Center and learned about the role of community health
workers in coordinating care of opiate using pregnant women
 Feels more resources are needed for primary care physicians on how to
identify and better assist opiate-using mothers
Amelia Carson, Clinical Care Coordinator at The Women’s Health Center
 Office performs drug screen on all pregnant woman as part of first prenatal
visit. The current struggle is bridging opiate replacement from when a mom
needs help until she can be placed into a buprenorphine substitution program

DEVELOPMENT AND IMPLEMENTATION
In talking to community members in Springfield, VT I identified several
challenges to good prenatal care in this population:
Pregnant moms may deny opiate use due to fear of legal consequences since
Vermont mandates notifying the Department of Children and Families (DCF)
In the primary care office it is challenging to have a non-threatening and
productive conversation on opiate use in pregnancy when suspected
Pregnant moms and providers alike may be unaware of the all the resources
available to opiate using pregnant women in the area

PROJECT: COMPILATION OF RESOURCES FOR PRIMARY
CARE PROVIDERS IN THE SPRINGFIELD AREA
Through discussions with community members in addition to identifying that opiate use
in pregnancy is an issue, I learned that some women avoid seeking prenatal care due
to fear of DCF involvement and the possibility that their child could be taken away. I
decided to put together a handout that explains what to expect during pregnancy as
an opiate user.
Many of the providers discussed the difficulty of finding buprenorphine prescribers so
I also attempted to locate all the area prescribers and medically-assisted treatment
programs within 1.5 hour drive of Springfield, VT. This way the handout could be
helpful to providers and patients.

The handout will be available for distribution at Turning Point, The ChildBirth Center,
and at a few sites associated with the Springfield Health Center including PCP offices
and the Women’s Health Center.

EVALUATION OF EFFECTIVENESS
In order to evaluate the effectiveness of this handout one could:
•Measure if there is an increase in pregnant women using opiates that seek prenatal
care in Springfield, VT

•Measure the number of pregnant women seeking buprenorphine or methadone
treatment
•Measure increased enrollment at the Parent Child Center

LIMITATIONS AND FUTURE WORK
With this handout I struggled between providing all the information I felt was
necessary and designing something that is brief and fits onto a smaller, less
intimidating pamphlet.

Next steps could include: educating PCPs to better screen for opiate misuse, providing
information to PCPs about opiate use in pregnancy and the resources available,
identifying other boundaries that prevent women using opiates from seeking prenatal
care, improving access to transportation in Springfield so that more women can take
advantage of area services, or coordinating with the BAMBI program in Rutland to
see if Springfield could work to have a more centralized system for providing all the
services necessary for pregnant women using opiates
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